Clinical Trials Browser

Phase 1/2 × vistusertib × Clear all

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT02730923 2024-02-13

VICTORIA

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

NCT03205046 2021-01-06

A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies

Phase 1/2 Terminated

25 enrolled 11 charts

DLBCL

NCT02583542 2020-02-25

TORCMEK

Phase 1/2 Unknown

Triple Negative Breast Neoplasms